Diffusion MRI of the Abdomen

Part of paid clinical trials in Madison, Wisconsin.

Sponsor
University of Wisconsin, Madison
Study ID
NCT05261633
Status
Recruiting

Conditions

  • Abdominal Imaging

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Diffusion Weighted Magnetic Resonance Imaging — DEVICE
    Diffusion-weighted (DW)-MRI has a unique ability to probe tissue microstructure without the need for ionizing radiation or intravenous contrast agents. DW-MRI of the abdomen is utilized in detection, staging, and treatment surveillance of malignancies, and has shown great promise in various other applications, including for the assessment of fibrosis in the liver, pancreas, kidneys, and other organs.

Study Details

The purpose of this research is to see if a new magnetic resonance imaging (MRI) method will be able to improve the images taken of the abdomen. This new method includes some changes to help avoid movements that may disrupt the images like breathing, heartbeats and other involuntary motion that occurs in the abdomen. This study will these methods in healthy volunteers and validate them in patients with known liver metastases in a single contrast-enhanced MRI visit.

Key Dates

Start date
Nov 22, 2023
Status verified
Nov 2025
Primary completion
Jun 30, 2026
Completion
Jun 30, 2026

Study Design

Enrollment
80 participants (estimated)

Arms

  • Arm: Healthy Volunteers
  • Arm: Known Liver Metastases

Primary Outcome Measure

Squared difference between each pair of repeated ADC measurements [ Time Frame: up to 1.5 hours ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Wisconsin School of Medicine and Public HealthMadisonWisconsin53792-

Find similar trials in Madison, WI